kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
fungiconazol
dechra regulatory -
dailiport 1 mg trde kapsule s podaljšanim sproščanjem
takrolimus - kapsula s podaljšanim sproščanjem, trda - takrolimus 1 mg / 1 kapsula - takrolimus
rokuronijev bromid kabi 10 mg/ml raztopina za injiciranje/infundiranje
rokuronijev bromid - raztopina za injiciranje/infundiranje - rokuronijev bromid 10 mg / 1 ml - rokuronijev bromid
advantan krema
krema - metilprednizolonaceponat
advantan mazilo
mazilo - metilprednizolonaceponat
advantan brezvodno mazilo
mazilo - metilprednizolonaceponat
genotan tablete 4 mg
tableta - metilprednizolon
medrol
tableta - metilprednizolon
medrol 100 mg
tableta - metilprednizolon